Pirmitegravir

Overview

Pirmitegravir is a potent and first-in-class inhibitor of allosteric integrase ( ALLINI ) that targets LEDGF/p75 binding site. Pirmitegravir displays picomolar IC 50 in human PBMCs with a >24,000 therapeutic index against HIV-1 . Pirmitegravir harbors outstanding anti-virus and safety properties.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HIV Integrase | Products > Signaling Pathways > HIV

Product Information

• Catalog No.: HY-130000
• CAS No.: 2245231-10-9
• Molecular Formula: C27H31ClN4O3
• Molecular Weight: 495.01
• Purity: 99.79%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source